Zimmer Biomet Holdings, Inc. Stock Mexican S.E.

Equities

ZBH *

US98956P1021

Medical Equipment, Supplies & Distribution

End-of-day quote Mexican S.E. 18:00:00 2024-05-14 EDT 5-day change 1st Jan Change
2,015 MXN -3.16% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% +8.91%

Financials

Sales 2024 * 7.76B 132B 10.58B Sales 2025 * 8.12B 138B 11.06B Capitalization 23.69B 403B 32.28B
Net income 2024 * 986M 16.75B 1.34B Net income 2025 * 1.19B 20.15B 1.62B EV / Sales 2024 * 3.61 x
Net Debt 2024 * 4.34B 73.73B 5.91B Net Debt 2025 * 3.03B 51.54B 4.13B EV / Sales 2025 * 3.29 x
P/E ratio 2024 *
23.6 x
P/E ratio 2025 *
20.4 x
Employees 18,000
Yield 2024 *
0.84%
Yield 2025 *
0.85%
Free-Float 64.77%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Zimmer Biomet Holdings, Inc.

1 day-3.16%
1 month-3.16%
3 months-4.28%
6 months+8.91%
Current year+8.91%
More quotes
1 month
2 015.00
Extreme 2015
2 015.00
Current year
2 015.00
Extreme 2015
2 105.00
1 year
1 850.11
Extreme 1850.11
2 483.11
3 years
1 850.11
Extreme 1850.11
3 393.68
5 years
1 850.11
Extreme 1850.11
3 483.50
10 years
1 850.11
Extreme 1850.11
3 483.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 18-10-31
Director of Finance/CFO 55 19-06-30
Chief Tech/Sci/R&D Officer - 21-06-06
Members of the board TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 68 08-12-31
Director/Board Member 51 14-12-11
More insiders
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
115.2 USD
Average target price
136.4 USD
Spread / Average Target
+18.42%
Consensus